BRONCHIAL ASTHMA

This study looked at the long-term safety of the drug roflumilast in adults with asthma. Participants had already finished a 24-week study and took the drug once daily for another 28 weeks. The goal was to see if the drug remained safe over a longer period.

This study tested a daily pill called roflumilast (APTA-2217) to see if it improves lung function in adults with asthma. About 450 participants took either the drug or a placebo for 24 weeks. Researchers measured breathing tests, asthma symptoms, and side effects to evaluate safe…

This early-stage study tested a new asthma medication called PA9159, given as an inhaled aerosol, in 40 healthy adults in China. The main goal was to see if it is safe and how the body processes it. Researchers monitored side effects, vital signs, and lab tests after single and r…

This study looked at how different amounts of aerobic exercise affect body fat, inflammation, and lung function in obese children with asthma. 72 children aged 8-18 were split into groups doing less than 75, 150, or 300 minutes of weekly exercise for 12 weeks. Researchers measure…

This completed study looked at over 107,000 patients in Germany to understand the long-term side effects of systemic steroids (corticosteroids) used for conditions like asthma, COPD, and arthritis. Researchers compared patients who took steroids with those who did not, tracking r…

This study looked at how the COVID-19 pandemic affected the quality of life of 200 adults with asthma. Researchers wanted to understand what caused extra stress—like staying home, using more disinfectants, or worrying that asthma symptoms might be COVID-19. The goal was to find o…